» Articles » PMID: 33557884

The De Novo CACNA1A Pathogenic Variant Y1384C Associated with Hemiplegic Migraine, Early Onset Cerebellar Atrophy and Developmental Delay Leads to a Loss of Cav2.1 Channel Function

Overview
Journal Mol Brain
Publisher Biomed Central
Date 2021 Feb 9
PMID 33557884
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

CACNA1A pathogenic variants have been linked to several neurological disorders including familial hemiplegic migraine and cerebellar conditions. More recently, de novo variants have been associated with severe early onset developmental encephalopathies. CACNA1A is highly expressed in the central nervous system and encodes the pore-forming Caα subunit of P/Q-type (Cav2.1) calcium channels. We have previously identified a patient with a de novo missense mutation in CACNA1A (p.Y1384C), characterized by hemiplegic migraine, cerebellar atrophy and developmental delay. The mutation is located at the transmembrane S5 segment of the third domain. Functional analysis in two predominant splice variants of the neuronal Cav2.1 channel showed a significant loss of function in current density and changes in gating properties. Moreover, Y1384 variants exhibit differential splice variant-specific effects on recovery from inactivation. Finally, structural analysis revealed structural damage caused by the tyrosine substitution and changes in electrostatic potentials.

Citing Articles

Pin1 promotes human Ca2.1 channel polyubiquitination by RNF138: pathophysiological implication for episodic ataxia type 2.

Fu S, Cheng K, Hsiao C, Fang Y, Jeng C, Tang C Cell Commun Signal. 2024; 22(1):571.

PMID: 39609819 PMC: 11603662. DOI: 10.1186/s12964-024-01960-9.


A structural analysis of the splice-specific functional impact of the pathogenic familial hemiplegic migraine type 1 S218L mutation on Ca2.1 P/Q-type channel gating.

Sack A, Samera G, Hissen A, Wester R, Garcia E, Adams P Mol Brain. 2024; 17(1):82.

PMID: 39568055 PMC: 11580629. DOI: 10.1186/s13041-024-01152-z.


A Review of the Gene Family: Its Role in Neurological Disorders.

Szymanowicz O, Druzdz A, Slowikowski B, Pawlak S, Potocka E, Goutor U Diseases. 2024; 12(5).

PMID: 38785745 PMC: 11119137. DOI: 10.3390/diseases12050090.


Two pediatric patients with hemiplegic migraine presenting as acute encephalopathy: case reports and a literature review.

Xiang Y, Li F, Song Z, Yi Z, Yang C, Xue J Front Pediatr. 2023; 11:1214837.

PMID: 37576133 PMC: 10419215. DOI: 10.3389/fped.2023.1214837.


The genotype-phenotype correlations of the -related neurodevelopmental disorders: a small case series and literature reviews.

Kessi M, Chen B, Pang N, Yang L, Peng J, He F Front Mol Neurosci. 2023; 16:1222321.

PMID: 37555011 PMC: 10406136. DOI: 10.3389/fnmol.2023.1222321.


References
1.
Eilers J, Plant T, Konnerth A . Localized calcium signalling and neuronal integration in cerebellar Purkinje neurones. Cell Calcium. 1996; 20(2):215-26. DOI: 10.1016/s0143-4160(96)90108-6. View

2.
Adams P, Garcia E, David L, Mulatz K, Spacey S, Snutch T . Ca(V)2.1 P/Q-type calcium channel alternative splicing affects the functional impact of familial hemiplegic migraine mutations: implications for calcium channelopathies. Channels (Austin). 2009; 3(2):110-21. DOI: 10.4161/chan.3.2.7932. View

3.
Wu L, Westenbroek R, BORST J, Catterall W, Sakmann B . Calcium channel types with distinct presynaptic localization couple differentially to transmitter release in single calyx-type synapses. J Neurosci. 1999; 19(2):726-36. PMC: 6782194. View

4.
Pietrobon D, Striessnig J . Neurobiology of migraine. Nat Rev Neurosci. 2003; 4(5):386-98. DOI: 10.1038/nrn1102. View

5.
Mullner C, Broos L, van den Maagdenberg A, Striessnig J . Familial hemiplegic migraine type 1 mutations K1336E, W1684R, and V1696I alter Cav2.1 Ca2+ channel gating: evidence for beta-subunit isoform-specific effects. J Biol Chem. 2004; 279(50):51844-50. DOI: 10.1074/jbc.M408756200. View